SSY Group Limited (2005.HK)

HKD 2.95

(0.0%)

Long Term Debt Summary of SSY Group Limited

  • SSY Group Limited's latest annual long term debt in 2023 was 1.94 Billion HKD , up 24.72% from previous year.
  • SSY Group Limited's latest quarterly long term debt in 2024 Q2 was 2.71 Billion HKD , down 0.0% from previous quarter.
  • SSY Group Limited reported annual long term debt of 1.56 Billion HKD in 2022, down -7.53% from previous year.
  • SSY Group Limited reported annual long term debt of 1.68 Billion HKD in 2021, up 53.53% from previous year.
  • SSY Group Limited reported quarterly long term debt of 1.94 Billion HKD for 2023 FY, up 24.72% from previous quarter.
  • SSY Group Limited reported quarterly long term debt of 1.94 Billion HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of SSY Group Limited (2023 - 2004)

Historical Annual Long Term Debt of SSY Group Limited (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 1.94 Billion HKD 24.72%
2022 1.56 Billion HKD -7.53%
2021 1.68 Billion HKD 53.53%
2020 1.09 Billion HKD 25.15%
2019 878.94 Million HKD -15.98%
2018 1.04 Billion HKD 23.31%
2017 848.35 Million HKD -9.24%
2016 934.73 Million HKD -16.94%
2015 1.12 Billion HKD 208.95%
2014 364.24 Million HKD -19.95%
2013 455.01 Million HKD 48.68%
2012 306.03 Million HKD 252.48%
2011 86.82 Million HKD 30.38%
2010 66.59 Million HKD 166.38%
2009 25 Million HKD -88.14%
2008 210.8 Million HKD -12.73%
2007 241.54 Million HKD 492.99%
2006 40.73 Million HKD 156.79%
2005 15.86 Million HKD -7.86%
2004 17.21 Million HKD 0.0%

Peer Long Term Debt Comparison of SSY Group Limited

Name Long Term Debt Long Term Debt Difference
Pak Fah Yeow International Limited 2.07 Million HKD -93849.298%
Grand Pharmaceutical Group Limited 990.02 Million HKD -96.718%
Extrawell Pharmaceutical Holdings Limited 117.12 Million HKD -1562.826%
Wai Yuen Tong Medicine Holdings Limited 276.2 Million HKD -605.13%
Qianhai Health Holdings Limited - HKD -Infinity%
Lee's Pharmaceutical Holdings Limited 70.63 Million HKD -2657.189%
Essex Bio-Technology Limited 36.05 Million HKD -5301.4%
Tongfang Kontafarma Holdings Limited 12.8 Million HKD -15114.186%
PuraPharm Corporation Limited 81.09 Million HKD -2301.647%
JBM (Healthcare) Limited 43.8 Million HKD -4346.502%
Jacobson Pharma Corporation Limited 592.2 Million HKD -228.87%
China Resources Pharmaceutical Group Limited 16.61 Billion HKD 88.28%